Patient Leaflet Updated 22-Dec-2025 | Flamingo Pharma (UK) Ltd
Ivabradine 5mg and 7.5mg film-coated tablets
Ivabradine 5mg and 7.5mg film-coated tablets
(Ivabradine)
1. What Ivabradine film-coated tablets are and what they are used for
2. What you need to know before you take Ivabradine film-coated tablets
3. How to take Ivabradine film-coated tablets
4. Possible side effects
5. How to store Ivabradine film-coated tablets
6. Contents of the pack and other information
Ivabradine is a heart medicine used to treat:
About stable angina pectoris (usually referred to as “angina”):
Stable angina is a heart disease which happens when the heart does not receive enough oxygen. The most common symptom of angina is chest pain or discomfort.
About chronic heart failure:
Chronic heart failure is a heart disease which happens when your heart cannot pump enough blood to the rest of your body. The most common symptoms of heart failure are breathlessness, fatigue, tiredness and ankle swelling.
How does this medicine work
The specific heart rate lowering action of ivabradine helps:
Talk to your doctor or pharmacist before taking Ivabradine film-coated tablets
If any of the above applies to you, talk straight away to your doctor before or while taking this medicine.
Ivabradine film-coated tablets is not intended for use in children and adolescents younger than 18 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Ivabradine film-coated tablets or monitoring should be required:
Avoid grapefruit juice during treatment with this medicine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Ivabradine film-coated tablets if you are pregnant or are planning to have a baby (see “Do not take Ivabradine film-coated tablets”).
If you are pregnant and have taken Ivabradine film-coated tablets, talk to your doctor.
Do not take Ivabradine film-coated tablets if you are able to become pregnant unless you use reliable contraceptive measures (see “Do not take Ivabradine film-coated tablets”).
Do not take Ivabradine film-coated tablets if you are breast-feeding (see “Do not take Ivabradine film-coated tablets”). Talk to your doctor if you are breast-feeding or intending to breast-feed as breastfeeding should be discontinued if you take Ivabradine film-coated tablets
Ivabradine film-coated tablets may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see “Possible side effects”). If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say it is essentially 'sodium free'.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Ivabradine film-coated tablets should be taken during meals.
If you are being treated for stable angina pectoris
The starting dose should not exceed one tablet of Ivabradine film-coated tablets 5 mg twice daily. If you still have angina symptoms and if you have tolerated the 5 mg twice daily dose well, the dose may be increased. The maintenance dose should not exceed 7.5 mg twice daily. Your doctor will prescribe the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine film-coated tablets 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
If you are being treated for chronic heart failure
The usual recommended starting dose is one tablet of Ivabradine 5mg film-coated tablets twice daily increasing if necessary to one tablet of Ivabradine 7.5mg film-coated tablets twice daily. Your doctor will decide the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine film-coated tablets 5 mg (correspond- ing to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
A large dose of Ivabradine film-coated tablets could make you feel breathless or tired because your heart slows down too much. If this happens, contact your doctor immediately.
If you forget to take a dose of Ivabradine film-coated tablets, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.
As the treatment for angina or chronic heart failure is usually life-long, you should discuss with your doctor before stopping this medicinal product.
If you think that the effect of Ivabradine film-coated tablets is too strong or too weak, talk to your doctor or pharmacist.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common adverse reactions with this medicine are dose dependent and related to its mode of action:
Very common (may affect more than 1 in 10 people)
Luminous visual phenomena (brief moments of increased brightness, most often caused by sudden changes in light intensity). They can also be described as a halo, coloured flashes, image decomposition or multiple images. They generally occur within the first two months of treatment after which they may occur repeatedly and resolve during or after treatment.
Common (may affect up to 1 in 10 people)
Modification in the heart functioning (the symptoms are a slowing down of the heart rate). They particularly occur within the first 2 to 3 months of treatment initiation.
Common (may affect up to 1 in 10 people)
lrregular rapid contraction of the heart (atrial fibrillation), abnormal perception of heartbeat (bradycardia, ventricular extrasystoles, 1st-degree AV block (ECG prolonged PQ interval)), uncontrolled blood pressure, headache, dizziness and blurred vision (cloudy vision).
Uncommon (may affect up to 1 in 100 people)
Palpitations and cardiac extra beats, feeling sick (nausea), constipation, diarrhoea, abdominal pain, spinning sensation (vertigo), difficulty breathing (dyspnoea), muscle spasms, high blood levels of uric acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a breakdown product of muscle), skin rash, angioedema (such as swollen face, tangue or throat, difficulty in breathing or swallowing), low blood pressure, fainting, feeling of tiredness, feeling of weakness, abnormal ECG heart tracing, double vision, impaired vision.
Rare (may affect up to 1 in 1,000 people)
Urticaria, itching, skin reddening, feeling unwell.
Very rare (may affect up to 1 in 10,000 people)
lrregular heartbeats (2nd-degree AV black, 3rd-degree AV black, sick sinus syndrome).
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. Vou can also report side effects directly via the Yellow Gard Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Gard in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after `EXP'. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is ivabradine (as hydrochloride).
Ivabradine 5 mg: Each film-coated tablet contains 5 mg ivabradine (as hydrochloride).
Ivabradine 7.5 mg: Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride).
The other ingredients are:
Tablet core
Lactose monohydrate, Cellulose microcrystalline, Croscarmellose sodium, Silica colloidal anhydrous, Magnesium stearate
Coating
Hypromellose (E464), Titanium dioxide (E171), Macrogol 6000 (E1521), Magnesium stearate (E470b), Glycerol (E422).
Ivabradine 5 mg: white colored, oval shape, biconvex, film coated tablet scored and engraved with '5' at one side, plain on the other. The tablet can be divided into equal doses.
Ivabradine 7.5 mg: white colored, round, biconvex, film coated tablet, engraved with '7.5' at one side and plain on the other.
The tablets are available in (Aluminium/aluminium blisters) of 14, 28, 56, 84, 98, 100 or 112 tablets.
Not all pack sizes may be marketed.
Marketing authorisation Number:
PL 43461/0174
PL 43461/0175
This leaflet was last revised in 11/2025
POM
MPLLIVAXXXXTBCOM
FPLXXX448V01_A
The BLOC, 38 Springfield Way, Kingston Upon Hull, HU10 6RJ, UK
+44 8000668348
+44 (0) 7784240228
http://www.flamingopharma.co.uk